PlainPill

Methylene Blue

The short answer. More people than not who report on Methylene Blue say it helped (64% of 37). It is most often used for focus: 100% of 23 reports say that improved. It is well studied — 131 meta-analyses on PubMed.

What users report
64%helped37 reports · medium confidence
24 helped7 mixed7 didn't help

From 132 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
131
meta-analyses
382
RCTs
27,814
papers

What Methylene Blue does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 131 meta-analyses on PubMed ↗ · 382 randomized trials ↗

Crit Care Explor · 2024 · Meta-analysis / systematic review
Methylene Blue in Septic Shock: A Systematic Review and Meta-Analysis

Conclusion: Among critically ill adults with septic shock, based on low-certainty evidence, MB may reduce short-term mortality, duration of vasopressors, and hospital length of stay, with no evidence of increased adverse events. Rigorous randomized trials evaluating the efficacy of MB in septic shock are needed.

PubMed 38904978 ↗
Braz J Anesthesiol · 2025 · Meta-analysis / systematic review
The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis

Conclusion: This meta-analysis demonstrated that methylene blue administration was associated with an increased in mean arterial pressure and PaO2/FiO2 ratio, along with a reduction in mortality rates, serum lactate levels, and length of hospital stay. However, substantial degree of heterogeneity and inadequate number of studies with low level of evidence warrant future adequately powered RCTs to affirm our results.

PubMed 39615751 ↗
Registered clinical trials

345 human trials on ClinicalTrials.gov test Methylene Blue — 182 completed, 36 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US government research funding (NIH)

NIH has funded 7 research projects with Methylene Blue in the title, $4,425,142 in total (1994–2018). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

0.5-5 mgdaily
1-5 dropsdaily
10 mgdaily
60 mcg3x daily approximately every 5 hours
200 mcg to 12 mgonce a week mentioned for safety
1 drop of 5%as reported

Reported side effects

How often each side effect came up across all reports.

green urine ×1color change ×1agitation ×1serotonin syndrome ×1tinnitus ×1urethral discomfort ×1hypertension ×1vomiting ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“Seems to be doing something. My Dual N back scores are up. My social anxiety also seems to be getting better. I am taking 60mcg 3x daily approximately every 5 hours.”
HelpedRead the discussion ↗
“Just 10mg and it's like my brain switches back on. I feel clear, focused, motivated...Brain fog is gone. Inflammation in my body is practically gone...I definitely don't feel more physically energized.”
MixedRead the discussion ↗
“First thing I noticed was mental clarity, not jittery like caffeine, just cleaner focus.”
MixedRead the discussion ↗
“I have noted really good benefits since day 1. I have been breathing much better...mental clarity. I cannot name any notably bad reactions.”
MixedRead the discussion ↗
Read more Methylene Blue reviews →
Top discussions (5)

Methylene Blue compared

Other options for focus

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate